Healthcare - Biotechnology - NASDAQ - US
$ 6.69
-11.6 %
$ 427 M
Market Cap
-5.82
P/E
CASH FLOW STATEMENT
-33.5 M
OPERATING CASH FLOW
33.4 M
INVESTING CASH FLOW
30 K
FINANCING CASH FLOW
FREE CASH FLOW ANALYSIS
Free Cash Flow Analysis
Larimar Therapeutics, Inc.
| Net Income | -36.9 M |
| Depreciation & Amortization | 311 K |
| Capital Expenditures | -164 K |
| Stock-Based Compensation | 7.62 M |
| Change in Working Capital | -2.51 M |
| Others | -4.03 M |
| Free Cash Flow | -33.6 M |
Cash Flow
Millions
| Dec-2023 | Dec-2022 | Dec-2021 | Dec-2020 | Dec-2019 | Dec-2018 | Dec-2017 | Dec-2016 | Dec-2015 | Dec-2014 | |
|---|---|---|---|---|---|---|---|---|---|---|
| OPERATING CASH FLOW | ||||||||||
| Net Income | (36.9) | (35.4) | (50.6) | (42.5) | (23.1) | (61.4) | (52.0) | (57.9) | (74.3) | (36.5) |
| Depreciation & Amortization | 0.3 | 0.3 | 0.3 | 0.2 | 78 K | 0.3 | 0.2 | 0.2 | 70 K | 16 K |
| Deferred Income Tax | 0 | 0 | 0 | 0 | 3.6 | (9.6) | 0 | 0 | (8.6) | (0.8) |
| Stock Based Compensation | 7.6 | 6.6 | 5.5 | 2.2 | 0.1 | 0.2 | 0 | 0 | 8.6 | 1.6 |
| Other Operating Activities | (1.9) | (0.8) | 15 K | 10 K | (3.6) | 9.8 | 9.1 | 10.6 | 9.1 | 6.7 |
| Change in Working Capital | (2.5) | 1.7 | 2.7 | (2.0) | 0.2 | 0.6 | 99 K | (5.5) | 6.7 | 0.8 |
| Cash From Operations | (33.5) | (27.6) | (42.1) | (42.2) | (22.7) | (51.5) | (43.8) | (52.0) | (59.6) | (28.2) |
| INVESTING CASH FLOW | ||||||||||
| Capital Expenditures | (0.2) | 100 K | (0.3) | 62 K | 83 K | (0.1) | 55 K | (0.7) | (0.6) | 58 K |
| Other Items | 33.5 | (90.9) | 24.5 | 17.2 | 0 | (6.8) | 35.7 | 52.1 | (91.5) | (57.3) |
| Cash From Investing Activities | 33.4 | (91.0) | 24.2 | 17.1 | 83 K | (6.9) | 35.6 | 51.4 | (92.1) | (57.3) |
| FINANCING CASH FLOW | ||||||||||
| Common Stock Repurchased | 0 | 0 | 0 | 0 | 0 | 67.2 | 0.2 | 0.2 | 131.0 | 0 |
| Total Debt Repaid | 0 | 0 | 0 | 0 | 0 | 0 | 16.4 | (2.9) | (1.4) | 7.3 |
| Dividends Paid | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Other Financing Activities | 30 K | 0 | 0 | 18.0 | 19.4 | 0 | 0 | 0 | 0 | 0 |
| Cash From Financing Activities | 30 K | 75.3 | 19.9 | 93.6 | 19.4 | 66.9 | 16.6 | (2.7) | 129.2 | 108.1 |
| CHANGE IN CASH | ||||||||||
| Net Change In Cash | 76 K | (43.3) | 1.9 | 68.5 | (3.4) | 8.6 | 8.4 | (3.2) | (22.5) | 22.6 |
| FREE CASH FLOW | ||||||||||
| Free Cash Flow | (33.6) | (27.7) | (42.4) | (42.3) | (22.8) | (51.6) | (43.8) | (52.6) | (60.1) | (28.3) |